Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-067785
Filing Date
2014-11-13
Accepted
2014-11-13 16:42:28
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v392936_10q.htm 10-Q 263147
2 EXHIBIT 31.1 v392936_ex31-1.htm EX-31.1 9912
3 EXHIBIT 32.1 v392936_ex32-1.htm EX-32.1 4555
  Complete submission text file 0001144204-14-067785.txt   4058804

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ttnp-20140930.xml EX-101.INS 683081
5 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20140930.xsd EX-101.SCH 36124
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20140930_cal.xml EX-101.CAL 26997
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20140930_def.xml EX-101.DEF 189817
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20140930_lab.xml EX-101.LAB 244038
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20140930_pre.xml EX-101.PRE 221834
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27436 | Film No.: 141218935
SIC: 2836 Biological Products, (No Diagnostic Substances)